Cargando…

Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells

After activation, some invariant natural killer T (iNKT) cells are differentiated into Klrg1(+) long-lived effector NKT1 cells. However, the regulation from the effector phase to the memory phase has not been elucidated. Zeb2 is a zinc finger E homeobox-binding transcription factor and is expressed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyoda, Tomonori, Shimizu, Kanako, Endo, Takaho, Watanabe, Takashi, Taniuchi, Ichiro, Aoshima, Honoka, Satoh, Mikiko, Nakazato, Hiroshi, Yamasaki, Satoru, Fujii, Shin-ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616117/ https://www.ncbi.nlm.nih.gov/pubmed/37903859 http://dx.doi.org/10.1038/s42003-023-05421-w

Ejemplares similares

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8(+) T cells against tumor
por: Shimizu, Kanako, et al.
Publicado: (2023)

Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
por: Fujii, Shin-ichiro, et al.
Publicado: (2022)

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells
por: Shimizu, Kanako, et al.
Publicado: (2015)

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies
por: Shimizu, Kanako, et al.
Publicado: (2020)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Eomes transcription factor is required for the development and differentiation of invariant NKT cells
por: Shimizu, Kanako, et al.
Publicado: (2019)

Optimal therapeutic strategy using antigen‐containing liposomes selectively delivered to antigen‐presenting cells
por: Iyoda, Tomonori, et al.
Publicado: (2019)

Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering
por: Okada, Masahiro, et al.
Publicado: (2023)

Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells
por: Fujii, Shin-ichiro, et al.
Publicado: (2017)

A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer
por: Shimizu, Kanako, et al.
Publicado: (2022)

Augmenting Granzyme B–Expressing NK Cells by Invariant NKT Ligand–Loaded APCs in Patients with Postoperative Early Stage Non–Small Cell Lung Cancer: Results of a Randomized Phase II Study
por: Iyoda, Tomonori, et al.
Publicado: (2023)

PD-L1 Expression Affects Neoantigen Presentation
por: Okada, Masahiro, et al.
Publicado: (2020)

Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2
por: Shimizu, Kanako, et al.
Publicado: (2021)

In vivo dendritic cell targeting cellular vaccine induces CD4(+) Tfh cell-dependent antibody against influenza virus
por: Yamasaki, Satoru, et al.
Publicado: (2016)

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ
por: Fujii, Shin‐ichiro, et al.
Publicado: (2022)

Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity
por: Seo, Wooseok, et al.
Publicado: (2020)

Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
por: Fujii, Shin-ichiro, et al.
Publicado: (2003)

A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma
por: Dhodapkar, Madhav V., et al.
Publicado: (2003)

Cbfβ2 controls differentiation of and confers homing capacity to prethymic progenitors
por: Tenno, Mari, et al.
Publicado: (2018)

Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune response
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN
por: Shimizu, Kanako, et al.
Publicado: (2019)

Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice
por: Matsuda, Masashi, et al.
Publicado: (2019)

Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients
por: Lezmi, Guillaume, et al.
Publicado: (2018)

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
por: Okada, Masahiro, et al.
Publicado: (2022)

Identification of a novel enhancer essential for Satb1 expression in T(H)2 cells and activated ILC2s
por: Nomura, Aneela, et al.
Publicado: (2023)

Histone Deacetylase 7 mediates tissue-specific autoimmunity via control of innate effector function in invariant Natural Killer T Cells
por: Kasler, Herbert G, et al.
Publicado: (2018)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

The two faces of invariant natural killer T cells
por: Walton, Emma L.
Publicado: (2015)

Metabolism in Invariant Natural Killer T Cells: An Overview
por: Yarosz, Emily L., et al.
Publicado: (2021)

Invariant natural killer T cells in lung diseases
por: Jeong, Dongjin, et al.
Publicado: (2023)

The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation
por: Carr, Tiffany, et al.
Publicado: (2015)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Lineage Differentiation Program of Invariant Natural Killer T Cells
por: Kwon, Dong-il, et al.
Publicado: (2017)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Development and Function of Invariant Natural Killer T Cells Producing T(H)2- and T(H)17-Cytokines
por: Watarai, Hiroshi, et al.
Publicado: (2012)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
por: Garner, Lucy C., et al.
Publicado: (2018)

Stage-specific epigenetic gene silencing during thymocyte lineage commitment
por: Taniuchi, Ichiro
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dd3hvvq6k66oblpcc2pj5anhlc